Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases.
Publication
, Journal Article
Chaudhry, V; Cornblath, DR; Griffin, JW; O'Brien, R; Drachman, DB
Published in: Neurology
January 9, 2001
The authors report the use mycophenolate mofetil (MM) in the treatment of neuromuscular diseases. Thirty-eight patients (32 with MG, three with inflammatory myopathy, and three with chronic acquired demyelinating neuropathy) were treated with MM for an average duration of 12 months. All patients tolerated MM without major side effects. Twenty-four patients improved either in their functional status or in their ability to reduce corticosteroid dose. Mean time to improvement was 5 months.
Duke Scholars
Published In
Neurology
DOI
ISSN
0028-3878
Publication Date
January 9, 2001
Volume
56
Issue
1
Start / End Page
94 / 96
Location
United States
Related Subject Headings
- Treatment Outcome
- Retrospective Studies
- Neurology & Neurosurgery
- Myositis
- Mycophenolic Acid
- Myasthenia Gravis
- Middle Aged
- Male
- Immunosuppressive Agents
- Humans
Citation
APA
Chicago
ICMJE
MLA
NLM
Chaudhry, V., Cornblath, D. R., Griffin, J. W., O’Brien, R., & Drachman, D. B. (2001). Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology, 56(1), 94–96. https://doi.org/10.1212/wnl.56.1.94
Chaudhry, V., D. R. Cornblath, J. W. Griffin, R. O’Brien, and D. B. Drachman. “Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases.” Neurology 56, no. 1 (January 9, 2001): 94–96. https://doi.org/10.1212/wnl.56.1.94.
Chaudhry V, Cornblath DR, Griffin JW, O’Brien R, Drachman DB. Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology. 2001 Jan 9;56(1):94–6.
Chaudhry, V., et al. “Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases.” Neurology, vol. 56, no. 1, Jan. 2001, pp. 94–96. Pubmed, doi:10.1212/wnl.56.1.94.
Chaudhry V, Cornblath DR, Griffin JW, O’Brien R, Drachman DB. Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology. 2001 Jan 9;56(1):94–96.
Published In
Neurology
DOI
ISSN
0028-3878
Publication Date
January 9, 2001
Volume
56
Issue
1
Start / End Page
94 / 96
Location
United States
Related Subject Headings
- Treatment Outcome
- Retrospective Studies
- Neurology & Neurosurgery
- Myositis
- Mycophenolic Acid
- Myasthenia Gravis
- Middle Aged
- Male
- Immunosuppressive Agents
- Humans